An eye to the future: Researchers debate best path for stem cell-derived therapies
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first in-human clinical trial of iPSC-based cell therapy used an iPSC-derived retinal pigment epithelium (RPE) sheet that was implanted into a Japanese woman with age-related macular degeneration (AMD) in 2014 [73,74].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [74]
In the citing paper
“This patient did not experience any complications during surgery or after the surgery, however, the patient was required to wait over 10 months for the surgery and it cost nearly USD 1 million [75].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [74]
Citations
Cites
Song, W. K., Park, K.-M., Kim, H.-J., Lee, J. H., Choi, J., Chong, S. Y., Shim, S. H., Del Priore, L. V., & Lanza, R. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.04.005 · Cited by 393
Cited by
Non-syndromic retinitis pigmentosa
Verbakel, S. K., van Huet, R. A. C., Boon, C. J. F., den Hollander, A. I., Collin, R. W. J., Klaver, C. C. W., Hoyng, C. B., Roepman, R., & Klevering, B. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.005 · Cited by 973
“Therefore, options for using human leukocyte antigen (HLA)-matched iPSCs from a databank are receiving increasing attention (Chakradhar, 2016; de Rham and Villard, 2014).”
Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0016-3 · Cited by 758
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283
“Even though there was no clear evidence that these mutations could directly lead to adverse effects, the planned transplantation surgery of iPSC-derived RPE sheet was cancelled [9, 10].”
BackgroundKirkeby, A., Nolbrant, S., Tiklova, K., Heuer, A., Kee, N., Cardoso, T., Ottosson, D. R., Lelos, M. J., Rifes, P., Dunnett, S. B., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.09.004 · Cited by 259
“As protocols to form authentic and functional cellular derivatives from hPSCs become increasingly refined, stem cell-based therapies are rapidly moving closer to clinical trials (Chakradhar, 2016).”
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
“…iPSCs retain the epigenetic memory of their tissue of origin, and spontaneous genetic mutations may be introduced through the experimental process (Chakradhar, 2016; Hu et al., 2010; Kim et al., 2010; Polo et al., 2010), iPSC cells can produce extracellular lipid and lipoprotein deposits…”
Background
Metadata
- Authors
- Chakradhar, S.
- Corresponding author
- Chakradhar, Shraddha
- Venue
- Nature Medicine
- Published
- 2016-02
- Volume
- 22
- Issue
- 2
- Pages
- 116-119
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2266236998
- Cited by
- 56
- References
- 1
- Citations by year
- 2025: 5 · 2024: 1 · 2023: 5 · 2022: 10 · 2021: 3 · 2020: 10 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 6
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- stem cell transplantation, age-related macular degeneration, dry age-related macular degeneration, visual acuity, tissue engineering, mesenchymal stem cells, pulmonary arterial hypertension, anti-inflammatory activity, immunomodulation
- MeSH terms
- Human Embryonic Stem Cells, Costs and Cost Analysis, Humans, Macular Degeneration, Mutation, Transplantation, Autologous, Transplantation, Homologous, Stem Cell Transplantation, Biomedical Research, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.